Clinical Trial Update: Thalidomide in Treating Patients With Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial of thalidomide for chronic myelomonocytic leukemia and myelodysplastic syndromes has completed. The study investigated thalidomide in these condit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes
• Myelomonocytic Leukemia

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED